217 related articles for article (PubMed ID: 19746656)
1. Time course of enrofloxacin and its active metabolite in peripheral leukocytes of dogs.
Boeckh A; Boothe D; Wilkie S; Jones S
Vet Ther; 2001; 2(4):334-44. PubMed ID: 19746656
[TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacokinetics of enrofloxacin and ciprofloxacin in lactating dairy cows and beef steers following intravenous administration of enrofloxacin.
Idowu OR; Peggins JO; Cullison R; Bredow Jv
Res Vet Sci; 2010 Oct; 89(2):230-5. PubMed ID: 20129633
[TBL] [Abstract][Full Text] [Related]
3. Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs.
Bidgood TL; Papich MG
J Vet Pharmacol Ther; 2005 Aug; 28(4):329-41. PubMed ID: 16050812
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of enrofloxacin in Korean catfish (Silurus asotus).
Kim MS; Lim JH; Park BK; Hwang YH; Yun HI
J Vet Pharmacol Ther; 2006 Oct; 29(5):397-402. PubMed ID: 16958784
[TBL] [Abstract][Full Text] [Related]
5. Plasma and ear tissue concentrations of enrofloxacin and its metabolite ciprofloxacin in dogs with chronic end-stage otitis externa after intravenous administration of enrofloxacin.
Cole LK; Papich MG; Kwochka KW; Hillier A; Smeak DD; Lehman AM
Vet Dermatol; 2009 Feb; 20(1):51-9. PubMed ID: 19152587
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of enrofloxacin in turkeys.
Dimitrova DJ; Lashev LD; Yanev SG; Pandova B
Res Vet Sci; 2007 Jun; 82(3):392-7. PubMed ID: 17107697
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentrations of enrofloxacin and its active metabolite ciprofloxacin in dogs following single oral administration of enrofloxacin at 7.5, 10, or 20 mg/kg.
Boothe DM; Boeckh A; Boothe HW; Wilkie S; Jones S
Vet Ther; 2002; 3(4):409-19. PubMed ID: 12584678
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the distribution of enrofloxacin by circulating leukocytes to sites of inflammation in dogs.
Boothe DM; Boeckh A; Boothe HW
Am J Vet Res; 2009 Jan; 70(1):16-22. PubMed ID: 19119944
[TBL] [Abstract][Full Text] [Related]
9. Tissue concentrations of enrofloxacin and ciprofloxacin in anesthetized dogs following single intravenous administration.
Boothe DM; Boeckh A; Boothe HW; Wilkie S
Vet Ther; 2001; 2(2):120-8. PubMed ID: 19753704
[TBL] [Abstract][Full Text] [Related]
10. Distribution of enrofloxacin and its active metabolite, using an in vivo ultrafiltration sampling technique after the injection of enrofloxacin to pigs.
Messenger KM; Papich MG; Blikslager AT
J Vet Pharmacol Ther; 2012 Oct; 35(5):452-9. PubMed ID: 21913941
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic behaviour of enrofloxacin in greater rheas following a single-dose intramuscular administration.
de Lucas JJ; Navarro JL; Rubio S; Vignolo PE; Asis VC; González F; Rodríguez C
Vet J; 2008 Jan; 175(1):136-8. PubMed ID: 17303451
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic behavior of enrofloxacin and its metabolite ciprofloxacin in urutu pit vipers (Bothrops alternatus) after intramuscular administration.
Waxman S; Prados AP; de Lucas JJ; San Andrés MI; Regner P; de Oliveira VC; de Roodt A; Rodríguez C
J Zoo Wildl Med; 2014 Mar; 45(1):78-85. PubMed ID: 24712165
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of enrofloxacin following intravenous administration to greater rheas: a preliminary study.
de Lucas JJ; Rodríguez C; Martella MB; Lábaque MC; Navarro JL; San Andrés MI
Res Vet Sci; 2005 Jun; 78(3):265-7. PubMed ID: 15766947
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin in chicken based on retrospective data, incorporating first-pass metabolism.
Guo QJ; Huang LL; Fang K; Wang YL; Chen DM; Tao YF; Dai MH; Liu ZL; Peng DP; Yuan ZH
J Vet Pharmacol Ther; 2010 Feb; 33(1):84-94. PubMed ID: 20444030
[TBL] [Abstract][Full Text] [Related]
15. Penetration of enrofloxacin into the nasal secretions and relationship between nasal secretions and plasma enrofloxacin concentrations after intramuscular administration in healthy pigs.
Bimazubute M; Cambier C; Baert K; Vanbelle S; Chiap P; Albert A; Delporte JP; Gustin P
J Vet Pharmacol Ther; 2010 Apr; 33(2):183-8. PubMed ID: 20444043
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and tissue distribution of enrofloxacin and its active metabolite ciprofloxacin in calves.
Davis JL; Foster DM; Papich MG
J Vet Pharmacol Ther; 2007 Dec; 30(6):564-71. PubMed ID: 17991225
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of the bovine formulation of enrofloxacin (Baytril 100) in horses.
Boeckh S; Buchanan C; Boeckh A; Wilkie S; Davis C; Buchanan T; Boothe D
Vet Ther; 2001; 2(2):129-34. PubMed ID: 19753705
[TBL] [Abstract][Full Text] [Related]
18. Enrofloxacin and marbofloxacin in horses: comparison of pharmacokinetic parameters, use of urinary and metabolite data to estimate first-pass effect and absorbed fraction.
Peyrou M; Bousquet-Melou A; Laroute V; Vrins A; Doucet MY
J Vet Pharmacol Ther; 2006 Oct; 29(5):337-44. PubMed ID: 16958777
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of enrofloxacin and its active metabolite ciprofloxacin in ill cows.
Fu LX; Jiang ZG; Ding HZ; Liu YH
J Vet Pharmacol Ther; 2008 Jun; 31(3):240-5. PubMed ID: 18471145
[TBL] [Abstract][Full Text] [Related]
20. Effect of Sucralfate on the Relative Bioavailability of Enrofloxacin and Ciprofloxacin in Healthy Fed Dogs.
KuKanich K; KuKanich B; Guess S; Heinrich E
J Vet Intern Med; 2016; 30(1):108-15. PubMed ID: 26651022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
